Questions? Call 888-624-8373

HARDBACK + PDF
your price: $56.50
add to cart

HARDBACK
list:$47.95
Web:$43.16
add to cart

PDF BOOK
your price: $37.00
add to cart

PDF CHAPTERS
your price: $2.90
select

Rights & Permissions

topleft topright

Complementary and Alternative Medicine in the United States (2005)
Board on Health Promotion and Disease Prevention (HPDP)

Page
98
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Complementary and Alternative Medicine in the United States

TABLE 3-4 Hierarchy of Evidence

Level

Emphasis on Efficacy

Emphasis on Effectiveness

I

Systematic Review (e.g., meta-analysis of Several Well-Controlled Randomized Trials—consistent results

Systematic Review (e.g., meta-analysis) of Several Well-Designed Outcome Studies or “Effectiveness RCTs”—consistent results

II

Single Well-Controlled Randomized Trial

Single Well-Designed Outcomes Study or “Effectiveness RCT”

III

Consistent Findings from Multiple Cohort, Case-Control, or Observational Studies

IV

Single Cohort, Case-Control, or Observational Study

V

Uncontrolled Experiment, Unsystematic Observation, Expert Opinion, or Consensus Judgments

SOURCE: IOM, 2001.

  • In general an RCT is the preferred study design if the issue is establishing treatment efficacy.

  • More studies are better than fewer studies, therefore a meta-analysis of multiple good RCTs is better than one good RCT.

  • Other study designs can provide evidence of efficacy or effectiveness.

  • Meta-analysis of multiple non-RCT studies is better than one non-RCT study. Meta-analysis of multiple non-RCT studies may or may not be better than one good RCT; it depends on the details of the studies and the specific question being asked.

  • If the question is treatment effectiveness, then some features of the typical RCT (stringent inclusion/exclusion criteria; treatment given in high-quality, high-volume clinical sites; detailed, frequent patient follow-up; etc.) create problems in generalizing findings to routine practice settings.

  • Other study designs, including observational studies or “effectiveness RCTs,” may provide evidence that is at least equally compelling as that provided by an “efficacy RCT.”

Effect size is another consideration that must be taken into account along with features of study design when one weighs the strength of evidence for a particular therapy. Treatments with clear, dramatic, positive effects in small or less well-controlled studies may be deemed “efficacious” sooner than treatments with more modest effects.

Page
98